PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
+1.98%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$7.69B
AUM Growth
+$7.69B
Cap. Flow
+$360M
Cap. Flow %
4.68%
Top 10 Hldgs %
39.16%
Holding
167
New
26
Increased
15
Reduced
34
Closed
16

Top Buys

1
NAUT icon
Nautilus Biotechnolgy
NAUT
$90M
2
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
$84.7M
3
UTHR icon
United Therapeutics
UTHR
$79.3M
4
ZY
Zymergen Inc. Common Stock
ZY
$65.3M
5
IOVA icon
Iovance Biotherapeutics
IOVA
$60.1M

Top Sells

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$46.6M
2
ALLO icon
Allogene Therapeutics
ALLO
$40.4M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
$39.9M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
$36.4M
5
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$35M

Sector Composition

1 Healthcare 85.23%
2 Financials 0.27%
3 Industrials 0.17%
4 Consumer Discretionary 0.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BLSA
101
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$10.5M 0.14%
1,000,000
– –
CTMX icon
102
CytomX Therapeutics
CTMX
$343M
$10.4M 0.13%
1,640,957
-513,017
-24% -$3.25M
RACB
103
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$10.1M 0.13%
1,000,000
– –
SMIHU
104
DELISTED
Summit Healthcare Acquisition Corp. Units
SMIHU
$10M 0.13%
+1,000,000
New +$10M
TBIO
105
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$9.35M 0.12%
+425,000
New +$9.35M
CNCE
106
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$9.08M 0.12%
2,150,641
– –
FDMT icon
107
4D Molecular Therapeutics
FDMT
$294M
$9.04M 0.12%
375,256
-69,622
-16% -$1.68M
PRVB
108
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$8M 0.1%
948,481
-1,903,577
-67% -$16M
PSTX
109
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$7.89M 0.1%
787,745
– –
ACHL
110
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
$7.4M 0.1%
755,375
– –
SILK
111
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$7.04M 0.09%
147,133
-192,967
-57% -$9.24M
DRIO icon
112
DarioHealth
DRIO
$22.6M
$7M 0.09%
327,869
– –
TSHA icon
113
Taysha Gene Therapies
TSHA
$786M
$6.79M 0.09%
320,440
-150,000
-32% -$3.18M
PRVA icon
114
Privia Health
PRVA
$2.84B
$5.99M 0.08%
+135,000
New +$5.99M
AKYA
115
DELISTED
Akoya BioSciences
AKYA
$5.8M 0.08%
+300,000
New +$5.8M
TNGX icon
116
Tango Therapeutics
TNGX
$705M
$5.69M 0.07%
500,000
– –
MREO
117
Mereo BioPharma
MREO
$278M
$5.38M 0.07%
1,696,068
-4,303,932
-72% -$13.6M
CHFW.U
118
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
$5.2M 0.07%
500,000
– –
PRTA icon
119
Prothena Corp
PRTA
$445M
$5.14M 0.07%
+100,000
New +$5.14M
LGV.U
120
DELISTED
Longview Acquisition Corp. II Units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable Warrant
LGV.U
$5.04M 0.07%
500,000
– –
OBIO icon
121
Orchestra BioMed
OBIO
$144M
$4.59M 0.06%
450,000
– –
TARA icon
122
Protara Therapeutics
TARA
$124M
$4.11M 0.05%
421,641
-1
-0% -$10
MRUS icon
123
Merus
MRUS
$5.05B
$3.69M 0.05%
175,000
– –
AMWL icon
124
American Well
AMWL
$109M
$3.65M 0.05%
290,000
-65,000
-18% -$818K
RGNX icon
125
Regenxbio
RGNX
$494M
$3.47M 0.05%
89,283
+20,000
+29% +$777K
3 4
5
6 7